30th June 2022, Seventh ParadigMS Symposium
ParadigMS Foundation organised organised in collaboration with the Belgian Multiple Sclerosis Study Group and endorsed by the Belgian Neurological Society, the ParadigMS Seventh Belgian Symposium that took place on the 30th of June both onsite and online. Here you can review the full keynote on Precision Medicine in MS.ABSTRACT
Precision medicine is a relatively new concept that has gathered considerable attention over the past 10 years or so. Within the context of multiple sclerosis (MS), precision medicine involves the use of genetics,...
9th December 2021, Pre-MENACTRIMS symposium, as a warm-up for the Sixth MENACTRIMS Congress, ParadigMS Foundation organised this enriching Pre-MENACTRIMS Symposium. Here you can review the full keynote on pregnancy and Lactation in Patients with MS.ABSTRACT
This session presents the most recent findings and updates for the treatment of pregnant or lactating MS patients. This includes family planning; the effect of pregnancy on the disease course, including relapses; post-partum disease activity; treatment during pregnancy and breastfeeding and the compatibility of disease modifying therapies...
9th December 2021, Pre-MENACTRIMS symposium, as a warm-up for the Sixth MENACTRIMS Congress, ParadigMS Foundation organised this enriching Pre-MENACTRIMS Symposium. Here you can review the full keynote on how to mitigate risks in MS.ABSTRACT
No two MS patients are the same, and yet only a limited number of disease-modifying therapies are available for MS neurologists to treat their patients. This session guides you in how to manage and mitigate risks associated with treating MS patients. You will take away a set of key messages stemming both from Professor Pugliatti’s own experience and literature...
9th December 2021, Pre-MENACTRIMS symposium, as a warm-up for the Sixth MENACTRIMS Congress, ParadigMS Foundation organised this enriching Pre-MENACTRIMS Symposium. Here you can review the full keynote on Human response to COVID-vaccination in MS.ABSTRACT
Most multiple sclerosis (MS) patients infected with COVID-19 had a mild-moderate infection, with no more relapses or more severe disease course than MS-free patients. This session shed light on the response to vaccination of MS patients, including the influence of the chosen MS treatment on vaccine response. Watch to hear more about the production...
24th June 2021, Sixth ParadigMS Symposium,The ParadigMS Foundation and the Belgian Study Group for Multiple Sclerosis (BSGMS) organised their annual symposium. Here you can review the full keynote on Innate Immunity and the Role of Microglia in MS.ABSTRACT
Multiple sclerosis is an autoimmune disease of the central nervous system characterised by inflammation in early stages, followed by neurodegeneration and progressive disability as the disease advances. Despite the fact that many disease-modifying therapies are now available, it is evident in many patients that disability continues to progress...
24th June 2021, Sixth ParadigMS Symposium,The ParadigMS Foundation and the Belgian Study Group for Multiple Sclerosis (BSGMS) organised their annual symposium. Here you can review the recorded report on the most important topics and interesting presentations at the European Academy of Neurology congress (EAN).ABSTRACT
Veronica Pospecu reported on the most important topics and most interesting presentations at the European Academy of Neurology congress (EAN), which took place from 19 to 22 June 2021.
VERONCA POPESCUDuring her neurology residency her interest in MRI was sparkled by the ISMRM MRI...
Free subscriptions to ParadigMS are reserved for healthcare practitioners. If you are a representative of the industry please contact us on learning@paradigms.foundation and we would advise you how to get the access to the material.
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, we will cancel your subscription immediately.
ParadigMS is designed specifically for healthcare practitioners, with content and language tailored to their professional needs. While patients cannot subscribe directly, we encourage you to consult your healthcare provider for relevant insights and updates that may benefit you.
Subscribing to ParadigMS’s e-platform gives you access to up-to-date information and valuable learning materials on multiple sclerosis and NMO, along with expert insights and the latest innovations in the field. It’s an essential resource for staying informed and enhancing your knowledge in MS care.
Yes, you can financially support ParadigMS! We welcome donations to help us continue our mission of advancing multiple sclerosis education and research. Your contribution directly supports the creation of educational resources, expert discussions, and innovative projects in MS care. Visit our donation page to learn more about how you can make a difference: ParadigMS Donate.